
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Goserelin Acetate
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Peptigroupe
Deal Size : Inapplicable
Deal Type : Inapplicable
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer
Details : Goserelin Acetate is a Peptide drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Prostatic Neoplasms.
Product Name : Undisclosed
Product Type : Peptide, Unconjugated
Upfront Cash : Inapplicable
August 16, 2019
Lead Product(s) : Goserelin Acetate
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Peptigroupe
Deal Size : Inapplicable
Deal Type : Inapplicable
